The Archimedes Pharma newsroom provides resources for journalists, including press releases, fact sheets and media contacts.
July 26th, 2013
Archimedes Pharma Ltd. announced today the sale of its US business and Lazanda
Archimedes Pharma Ltd. announced today the sale of its US business and more specifically Lazanda Nasal Spray to Depomed Inc., a specialty pharmaceutical company that is
focused on developing and commercializing products to treat pain.
Depomed operates its business out of Newark, California.
Depomed currently markets two other products for relief of mild to moderate acute pain.
Archimedes remains committed, focused and enthusiastic about expanding and growing our European and Rest of World business.